BioCardia, Inc.
BCDA • NASDAQ
BioCardia, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter A. Altman, with a market cap of $12.3M.
CEOPeter A. Altman
Next Earnings
Upcoming earnings announcement for BioCardia, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.16
Revenue Estimate
$35.0K
Earnings History
Past 12 earnings reports for BioCardia, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.06Est: -$0.20 | +70.0% | -Est: $20.0K | -100.0% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.24Est: -$0.25 | +4.0% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.40 | — | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.59 | — | - | — | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$0.25Est: -$0.87 | +71.3% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.61 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.88 | — | $3.0K | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.35Est: $0.00 | — | $55.0K | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$1.35Est: -$1.65 | +18.2% | $13.0KEst: $90.0K | -85.6% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$1.80Est: -$1.80 | 0.0% | $357.0KEst: $20.0K | +1685.0% | — |
| Aug 9, 2023 | Q2 2023 | -$2.55Est: -$2.40 | -6.2% | $43.0KEst: $120.0K | -64.2% | — |
| May 10, 2023 | Q1 2023 | -$2.55Est: -$2.40 | -6.2% | $64.0KEst: $340.0K | -81.2% | — |